Comparison of biological and socioeconomic risk factors of maternal mortality, in Pakistan (PDHS 2007 and PMMS 2019) (see note 1). by Farid Midhet (17403945)

Subjects:

Comparison of the association between maternal mortality in rural areas and distance to a hospital providing CEmONC and distance to public transport, Pakistan 2007 and 2019 (see no... by Farid Midhet (17403945)

Subjects:

Mean mesenteric, retroperitoneal, pericardial, and total visceral adipose tissue weights (in grams) upon completion of the experiment. by Elsie D. Oduor (22521785)

Subjects:

Line graph illustrating mean body weight (in grams) at weekly intervals during the induction phase. by Elsie D. Oduor (22521785)

Subjects:

Expression analysis of downstream target genes in the IL-10 signaling pathway across myeloid leukemia cell lines. by Ajeet P. Singh (22298432)

Subjects:

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

MMR (maternal deaths per 100,000 live births) and 95% confidence limits, PDHS 2007 and PMMS 2019. by Farid Midhet (17403945)

Subjects:

Line graph illustrating mean body weight (in grams) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Mean lipid profile (mmol/L) upon completion of the experimental period. by Elsie D. Oduor (22521785)

Subjects:

EF-24 treatment modulates gene expression in THP-1 cells. by Ajeet P. Singh (22298432)

Subjects:

SPSS data analysis files. by Farid Midhet (17403945)

Subjects:

Expression analysis of downstream target genes in the p38/MAPK signaling pathway across myeloid leukemia cell lines. by Ajeet P. Singh (22298432)

Subjects:

Line graph illustrating mean food intake (g) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Mean blood glucose responses (mmol/L) to an oral blood glucose bolus 2g/kg during a 120-minute period and mean area under the curve (mmol/L.min) during the oral blood glucose toler... by Elsie D. Oduor (22521785)

Subjects:

EF-24 treatment disrupts key molecular pathways associated with cell survival, proliferation, and viability. by Ajeet P. Singh (22298432)

Subjects:

Representative liver histology of normal control (A), low-dose Olanzapine (B), negative control (C), test (D), and positive control (E) groups (Hematoxylin and Eosin stain, ×400 ma... by Elsie D. Oduor (22521785)

Subjects:

Preference for the EIA – conjoint results. by Mehdi Mourali (10170245)

“…When are individuals more likely to support equal treatment algorithms (ETAs), characterized by higher predictive accuracy, and when do they prefer equal impact algorithms (EIAs) that reduce performance gaps between groups? …”

Marginal means – Pooled across scenarios. by Mehdi Mourali (10170245)

“…When are individuals more likely to support equal treatment algorithms (ETAs), characterized by higher predictive accuracy, and when do they prefer equal impact algorithms (EIAs) that reduce performance gaps between groups? …”

Sample attribute table. by Mehdi Mourali (10170245)

“…When are individuals more likely to support equal treatment algorithms (ETAs), characterized by higher predictive accuracy, and when do they prefer equal impact algorithms (EIAs) that reduce performance gaps between groups? …”

Subgroup analysis – Political affiliation. by Mehdi Mourali (10170245)

“…When are individuals more likely to support equal treatment algorithms (ETAs), characterized by higher predictive accuracy, and when do they prefer equal impact algorithms (EIAs) that reduce performance gaps between groups? …”